As a drug improving energy metabolism, deproteinized calf blood extract has received wide attention due to its efficacy in nervous system. Currently, it is mainly used to treat brain disease, nervous system disease, vascular disease, ulcer, burn, radiation injury and eye disease.
Developed by Jaeger KH with membrane filtering technology, deproteinized calf blood extract is the deproteinized blood extract of new- born calf with a relative molecular mass of less than 6000 dalton. Since the 1960s, deproteinized calf blood extract has been marketed all over the world.
Recently, nervous system drug has reported a stable growth. Among the TOP500 drugs in the seven big markets, nervous system drug reported a sales value of USD 43.286 billion with a year- on- year growth of 3% in 2013. Brain system drug, in particular, has undergone a downturn in global market. However, as people become increasingly aware of the pathogenesis and clinical pharmacology of neurologic diseases, the market of neurologic drug has grown fast in China. As a leading neurologic drug, deproteinized calf blood extract has reported a large sales in China. By the end of August 2015, there are 18 manufacturers of deproteinized calf blood extract and deproteinized calf blood extract injection, 3 manufactures of deproteinized calf blood extract ophthalmic gel and 1 manufacturer of deproteinized calf blood extract capsule.
According to this market survey, the sales value of deproteinized calf blood extract in sample hospitals reached about CNY 1.2 billion and CAGR during the period of 2005- 2014 surpassed 30%. Jinzhou Ahon Pharmaceutical Co., Ltd, Heilongjiang Jiangshi Pharmaceutical Co., Ltd, Harbin Sanctity Pharmaceutical Co., Ltd, Jilin Connell Pharmaceutical Co., Ltd and Wuhan Humanwell Pharmaceutical Co., Ltd occupy the market, among which Jinzhou Ahon Pharmaceutical Co., Ltd had the largest market share of about 71% for sales value in 2014.
The market size of deproteinized calf blood extract in China is expected to keep growing in next few years.
Readers can get the following information through this report:
- market size of deproteinized calf blood extract in China
- competitive landscape of deproteinized calf blood extract market in China
- price of deproteinized calf blood extract made by different enterprises in China
- market outlook of deproteinized calf blood extract in China
The author suggests the following groups of people purchase this report:
- drug makers
- investors/research institutions interested in Chinese medicine market
1 Related Concepts of Deproteinized Calf Blood Extract
Chart Patent Information of Deproteinized Calf Blood Extract in China
select a license
NEWSLETTER BY CATEGORY
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"
We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"
I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"
I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "
The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"